Sign up for the email list
We just wanted to take a moment to let you know how wonderful Allison Gamber is! She did a training recently at our daughter's school, and had done two... Kris
New Drug for Lennox-Gastaut Syndrome (LGS) Patients Now Available01/03/2012
Lundbeck announced today that ONFI (clobazam) tablets are now available for prescribing in the United States. We previously reported on ONFI in October when the FDA approved ONFI for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years and older. Clobazam is an oral anti-epileptic drug (AED) of the benzodiazepine class, and is a 1,5 benzodiazepine. ONFI is a federally controlled schedule four substance (C-IV).
Back To All News